BCL2 and breast carcinoma: Another study indicated that RA and/or paclitaxel inhibited tumor growth in breast cancer models by increasing the levels of P53 and caspase-3 and inhibiting the Bcl2/Bax ratio (Mahmoud et al., 2021).